Connection

Eman Toraih to Glioblastoma

This is a "connection" page, showing publications Eman Toraih has written about Glioblastoma.
Connection Strength

3.119
  1. Expression of long intergenic non-coding RNA, regulator of reprogramming, and its prognostic value in patients with glioblastoma. Int J Biol Markers. 2019 Mar; 34(1):69-79.
    View in: PubMed
    Score: 0.619
  2. Deregulated MicroRNA Signature Following Glioblastoma Irradiation. Cancer Control. 2019 Jan-Dec; 26(1):1073274819847226.
    View in: PubMed
    Score: 0.611
  3. Long noncoding RNA H19, and not microRNA miR-326, is over-expressed and predicts survival in glioblastoma. Biochem Cell Biol. 2018 12; 96(6):832-839.
    View in: PubMed
    Score: 0.595
  4. Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme. Oxid Med Cell Longev. 2018; 2018:8753063.
    View in: PubMed
    Score: 0.579
  5. MicroRNA-target cross-talks: Key players in glioblastoma multiforme. Tumour Biol. 2017 Nov; 39(11):1010428317726842.
    View in: PubMed
    Score: 0.564
  6. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors. PLoS One. 2018; 13(10):e0198231.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.